APOM-project: A first study of pharmacy organization and management

Pharmacy World and Science

Volumn 20, Issue 5, 1998, Pages 219-224

  Mobach, Mark P ^a   Van Der Werf, Jos J ^a   Tromp, Th F J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Community pharmacy; Management; Organization structure; Pharmacy organization; Strategy; Working organization

Indexed keywords

ARTICLE; MANAGEMENT; NETHERLANDS; ORGANIZATION; PHARMACY;

COMMUNITY PHARMACY SERVICES; HUMANS; NETHERLANDS; PHARMACY ADMINISTRATION; PILOT PROJECTS;

EID: 0031771320     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008603502726     Document Type: Article

References (57)

1. Mobach MP, Werf JJ van der, Tromp TFJ. A survey of pharmacy organization and management. Pharm World Sci. (In Press.)
2. World Health Organization (WHO). The role and the function of the community and hospital pharmacist in the health-care systems of Europe. Groningen: Styx publications, 1989:5-55.
3. Stoner JAF, Wankel C. Management. Englewood Cliffs/New Jersey: Prentice Hall International Editions, 1986:111-2.
4. KNMP (Royal Dutch Association for the Advancement of Pharmacy), Apotheek kwaliteitszaak - beleidsplan van de Nederlandse apotheker, (Pharmacy, a case of quality - policy plan of the Dutch pharmacist). Den Haag: KNMP, 1991:1-29.
5. Cancrinus-Matthijsse A. Tussen hulpverlening en ondernemerschap - beroepsuitoefening en taakopvattingen van openbare apothekers in een aantal West-Europese landen (between assistance and entrepreneurship - professional exercise and task opinion of community pharmacists in a number of Western European countries). Thesis Publishers: Amsterdam, 1995.
6. Werf JJ van der. Openbare apotheker op een kruispunt - marktwerking in een gepolitiseerde branche!? (Public pharmacy on the crossroad - market forces in a politicized enterprise). Pharm Weekbl 1996;131(6):160-4.
7. Jong JGAM de. De apotheker; beroepsbeoefenaar met vele gezichten (The pharmacist; professional practioner with many faces). Rede uitgesproken bij de aanvaarding van het ambt van bijzonder hoogleraar in de bedrijfskundige aspecten van de farmaceutische beroepsuitoefening vanwege OPG aan de Rijksuniversiteit Utrecht, Rotterdam, January 1992:9-24.
8. Anonymous. Pharmacy. The report of a committee of inquiry appointed by the Nuffield Foundation. London: Nuffield Foundation, 1986:16.
9. Bergman U, Wilholm BE. Drug related problems causing admission to a medical clinic. Eur J Pharmacol 1981;(20): 193-200.
10. Blackwell B. The drug defaulter. Clin Pharmacol Ther 1972;(13):841.
11. Blom LThG. Developing patient education in community pharmacy practice. Utrecht: Elinkwijk, 1996.
12. Castro I, Bonal, J, et al. The role of the therapeutic committee in the quality control programme of the hospital de la Sant Creu and Sant Pau. Sant Pau: 1987:38-43.
13. Evans L, Spelman M. The problem of non-compliance. Drugs, 1983;(25):63-76.
14. Holmberg L, Böttiger LE. The drug-consuming patient and his drugs. Acta Med Scand 1983;(213):205-16.
15. Hood JC, Murphy JE. Patient noncompliance can lead to hospital readmissions. Hospitals J.A.H., 1978; (A52):79-84.
16. KNMP (Royal Dutch Association for the Advancement of Pharmacy). Apotheek-, Werk- en Kontrolenormen (AWEK), (Pharmacy, Work and Check Standards). Den Haag: KNMP, March 1988:11-12,21.
17. KNMP (Royal Dutch Association for the Advancement of Pharmacy). Nederlandse Apotheeknorm (NAN), (Dutch Pharmacy Standard). Den Haag: KNMP, April 1996.
18. Kruithof B. Het conflict tussen apothekers en drogisten - de professionalisering van twee beroepsgroepen tussen 1865 en 1932 (The conflict between pharmacists and chemists). Bohn Stafleu Van Loghum, 1995.
19. Latiolais C, Berry C. Misuse of prescription medications by outpatients. Drug Intell Clin Pharm 1969;(3):270.
20. Mann RD. Risk and consent to risk in medicine. Carnforth: Parthenon Publishing Group Ltd, 1989:24-25.
21. Mobach MP, Werf JJ van der. Het baliemodel in de apotheek (The counter model in pharmacy examined). Pharm Weekbl 1993:128(33/34):998-1002.
22. Mobach MP. The work at the pharmacy: Sweden and the Netherlands compared. Pharm World Sci 1994;16(4):193-200.
23. Nielsen PL. Receptkontroll. Farm Tidene 1984;(94):913-20.
24. Paes AHP. Apotheker en artsen in overleg? - kontakten in de eerste Iijn (Pharmacists and general practitioners in consultation? - contacts in primary health care). Utrecht, 1989:32-3.
25. Parkin DM, Henney CR, Quirk J, Crooks J. Deviation from prescribed drug treatment after discharge from hospital. Brit Med J 1976;(2):686.
26. Pothier PE. Patients compliance in therapy. Drug Intell Clin Pharm 1976;(10):318.
27. Sackett TL, Haynes RB. Compliance with therapeutic regimens. Baltimore: John Hopkins University Press, 1976.
28. Tolo KW, Dinkel R, Horisberger B. Improving drug safety - a joint responsibility. Berlin/Heidelberg: Springer-Verlag, 1991:55,66.
29. Trigt AM van. Making news about medicines. Enschede: Febo, 1995.
30. Tromp TFJ. Apotheker op koers (Pharmacist on course). Pharm Weekbl 1990;125(44):1132-8.
31. Verbeek-Heida P. De eigen wijsheid van de patient, alledaagse overwegingen bij geneesmiddelen gebruik (The impertinence (own wisdom) of the patient). Amsterdam, 1992:9-10.
32. Winters J. Management of pharmaceutical services in community pharmacy. In Proceedings of the International Symposium on the Management of Clinical Pharmacy Services. Barcelona: Rasgo Editorial S.A., 1986:121-128.
33. World Health Organization (WHO). Second meeting on the role of the pharmacist: quality pharmacuetical services, benefits for governments and the public (pharmaceutical care). Tokyo: WHO, 1993.
34. Zijlstra IF. De regionaal klinisch farmacoloog - farmacotherapie overleg met huisarts en apotheker (The area clinical pharmacologist - pharmacotherapy consultation in general practice). Groningen, 1991:7-8.
35. Anonymous. Overheid tornt aan monopolie apotheker - Ook medicijnen laten verkopen door supermarkten (Government unstitches monopoly pharmacist - Sell medicine in supermarkets). Algemeen Dagblad, 23 February 1994.
36. Apoteksbolaget AB. Pharmacies in Sweden, annual report 1992 for Apoteksbolaget AB. Stockholm: Ehrenstråhle & Co, 1993:6.
37. Carroll NV. Financial management for pharmacists - a decision making approach. Beckenham: Lea & Febiger, 1991:1-2.
38. Draugalis JR, Bootman JL, Larson LN, McGhan WF. Pharmacoeconomics, current concepts. Kalamazoo, MI: The Upjohn Company, 1989:6-11.
39. Goseling C. Traditionele apotheken verdwijnen in plan kabinet (Traditional pharmacies disappear in plan of cabinet). Utrechts Nieuwsblad, 22 February 1994; quoted in 'Uit de media', OPG;(192), 24 February 1994.
40. Stoddard GL, Drummond MF. How to read clinical journals: to understand an economic evaluation. Can Med Assoc J 1984;130:1428-34.
41. Werf JJ van der, t'Sas TH, Oosterveld MH, Jong-van den Berg LTW de, Reekum AH van. De arbeidsorganisatie van de openbare apotheek (The working organization of the community pharmacy). Pharm Weekbl 1995; 130(15):382-9.
42. Wiarda Beckmann Stichting. Winst op recept - De geneesmiddelenvoorziening in Nederland (Profit on prescription - The medicine provision in the Netherlands). Deventer: Kluwer, 1977:127-8.
43. Wöhe G. Einführung in die Algemeine Betriebswirtschaftlehre (Introduction to General Business Administration), München: Verlag Franz Vahlen GmbH, 1974:38.
44. Fornell C. A National Customer Satisfaction Barometer (The Swedish Experience). Michigan: University of Michigan, School of Business Administration, January 1991:1.
45. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Pharm Ed 1990;47:533-43.
46. Russell CG, Wilcox EM, Hicks Cl. Interpersonal communication in pharmacy - an interactionist approach. New York: Appleton-Century-Crofts, 1982:1-2.
47. Strand LM, Cipolle RJ, Morley PC. Pharmaceutical care: an introduction, current concepts. Kalamazoo, MI: The Upjohn Company, 1992:6.
48. Wertheimer Al, Smith MC. Pharmacy practice, social and behavioral aspects. Baltimore: University Park Press, 1981:107.
49. Hildebrandt H. Gesundheitsförderung und die Apotheke der Zukunft (Health stimulation and the pharmacy of the future), Pharm Zeit 1992:35(137).
50. KNMP (Royal Dutch Association for the Advancement of Pharmacy). Apotheek kwaliteitszaak - beleidsplan van de Nederlandse apotheker (Pharmacy, Quality Business - Policy plan of the Dutch pharmacist). Den Haag: KNMP, 1991:1,29.
51. KNMP (Royal Dutch Association for the Advancement of Pharmacy), KNMP-ledenpeiling 1993 - Verslag van een onderzoek onder openbare apothekers, (KNMP-Member Sounding 1993 - Report of a study among community pharmacists), Den Haag: KNMP, December 1993:8-9,18,26.
52. Leufkens HGM. Het Nuffield-rapport: optimisme en vertrouwen in de Engelse farmacie (The Nuffield report: optimism and confidence in the English pharmacy). Pharm Weekbl 1987;122:401-5.
53. Snier H. Concurrentie & strategie in de geneesmiddelensector (Competition & strategy in the Pharmaceutical Sector). Thesis. Eburon: Delft, 1995.
54. Pols B. Opkomst postorderfarmacie maakt apothekers nerveus, (Origin of mail order pharmacy makes pharmacists nervos). NRC Handelsblad, 11 februari 1994.
55. Tromp TFJ. De toekomst is aan ons (The future is ours). Pharm Weekbl 1991;126(46):1157-62.
56. Wolf P de, Snier H, Kruijff Ml de, Rooij JM van. Diagnose van de boycot van postorderfarmacie (Diagnosis of the Boycot of Mail-order Pharmacy). Rotterdam: Erasmus Universiteit Rotterdam, Faculteit Bedrijfskunde, vakgroep Strategie en Omgeving, 1995.
57. Anonymous. Report on the meeting of the 'Good Pharmacy Practice' Working Group. Brussel: PGEU (Pharmaceutical Group of the European Union) 17-01-1994.